focus -WSS

focus

author：leisure time 2025-10-01 11:46:15 - browse：426

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The EU Joint Clinical Assessment needs to live up to its promise

leisure time

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

FDA gives detailed accounting of AI

Hospital price transparency does save money, advocate argues

Asbestos ban is immediate, but health effects will linger for decades

Pharmacists can make shortage drugs, but at what cost?

NIH confirmation hearing shows politicization of research

focus

focus

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Pregnancy ages women, but effects reverse after delivery

How to save PrEP access — and even expand it

What Kate Middleton's cancer revelation might teach the world

Novavax promises a turnaround & Lilly roils the obesity market

Asbestos ban is immediate, but health effects will linger for decades

Hepatitis C has a cure — but many Americans still lack access to it

STAT Summit: How a Chicago ER doctor tackles gun violence

State Dept. review finds Biden bears some blame for Afghanistan failures

Pfizer, Moderna say biotech, pharma drug development is a sprint

knowledge

STAT Summit: Michael J. Fox on progress in Parkinson's research

Steward Health Care expansion into Malta flopped

Beam Therapeutics to lay off 20% of its staff, re

Researchers explore possible ties between long Covid, menopause

Mirador, a new biotech startup, launches with $400 million

Cancer, immunology, HIV research ensnared in fetal tissue politics

focus

leisure time

Wikipedia

entertainment